Loading insider details...
Latest Form 4 (Jun 16, 2026): Grant/Award of 22,100 LENZ shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 22,100 | n/a |
| Jun 11, 2026 | Nkarta, Inc. (NKTX) | Grant/Award | 37,000 | n/a |
| Feb 9, 2026 | SpyGlass Pharma, Inc. (SGP) | Grant/Award | 27,400 | n/a |
| Jun 11, 2025 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 13,500 | n/a |
| Jun 9, 2025 | Nkarta, Inc. (NKTX) | Grant/Award | 46,000 | n/a |
| Jun 14, 2024 | Nkarta, Inc. (NKTX) | Grant/Award | 22,500 | n/a |
| Mar 26, 2024 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 27,000 | n/a |
| Jun 9, 2023 | Nkarta, Inc. (NKTX) | Grant/Award | 22,500 | n/a |
| Jun 10, 2022 | Nkarta, Inc. (NKTX) | Grant/Award | 16,000 | n/a |
| Jun 15, 2021 | Nkarta, Inc. (NKTX) | Grant/Award | 16,511 | n/a |